Viewing Study NCT02650635


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-01-02 @ 8:00 AM
Study NCT ID: NCT02650635
Status: TERMINATED
Last Update Posted: 2018-09-05
First Post: 2015-12-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module